RecruitingACTRN12618001123235

Pilot study on feasibility of Intensive care unit bereavement follow-up service for family representatives of patients who die in the Intensive Care Unit (ICU).

Pilot study on feasibility of intensive care unit bereavement follow-up service for family representatives of patients who die in the Intensive Care Unit (ICU).


Sponsor

Nikki Yeo

Enrollment

360 participants

Start Date

Feb 1, 2018

Study Type

Observational

Conditions

Summary

Around 30% of deaths at the Royal Adelaide Hospital (300 per annum) occur in the ICU or shortly after leaving ICU. The importance of reviewing end-of-life care in the ICU is well recognised. Benefits include assisting family members to process their grief and the opportunity to improve the care delivered to dying patients. Primary aim of this study is to establish the feasibility of delivering a bereavement service by the intensive care unit. Secondary aims are to assess the value of feedback received about the end-of-life care and how the service is viewed by family members. This is a prospective, observational study. All family representatives of patients who die in ICU are included in the study. They are excluded if a family representative is not contactable or declines participation.. Patients are referred to the bereavement follow-up service at medical consensus of end-of-life. After the patient's death, the appropriate family representative will be given a brochure providing bereavement information and a letter outlining the follow-up service. The 30 minute interview is based on the validated CAESAR tool, focused on care around the end-of-life. The responses will be recorded as Likert scores with the option to provide qualitative feedback. The bereavement calls will be made at 4 weeks, by clinicians who are experienced intensive care clinicians. The telephone interview questionnaire consists of 16 questions in 4 sections. The first section of the questionnaire relates to the care of the patient and support for the family. The second section relates to the communication between ICU and the family. The care of the patient and the discussion around organ donation are covered in the next two sections. The last section consists of open-ended question relating to how the family member feel the end-of-life care can be improved.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study is about supporting families who have lost a loved one in an intensive care unit (ICU). Losing someone in the ICU can be a profoundly difficult experience, and families often have questions about the care that was provided and need emotional support in the weeks that follow. This study tests whether a structured phone call from experienced ICU clinicians — made about four weeks after a patient's death — can be helpful and practical to implement. The phone call lasts about 30 minutes and follows a structured questionnaire called the CAESAR tool. It asks about communication with the ICU team, the care of the patient, end-of-life discussions, and anything the family feels could be improved. Responses are recorded to help the hospital understand and improve how it cares for dying patients and their families. If you are a family member or representative of a patient who passed away in the ICU at Royal Adelaide Hospital, you may be contacted about this service. Participation is entirely voluntary, and you can choose not to take part. The goal is to provide a safe space for families to share their experience and for the hospital to learn and improve the care it provides at one of the most sensitive times in anyone's life.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Prospective, single-centre observational study. Nominated family representative is identified at time of patient's death. The representative is contacted at 4 weeks. With his/her consent, a structu

Prospective, single-centre observational study. Nominated family representative is identified at time of patient's death. The representative is contacted at 4 weeks. With his/her consent, a structured telephone interview is completed. Each telephone interview is anticipated to take around 30 minutes. The interview is based on the validated CAESAR tool, focused on care around the end-or-life. The areas covered include care, support and communication with patient and family, medical treatment of patient and discussion around organ donation.


Locations(1)

The Royal Adelaide Hospital - Adelaide

SA, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12618001123235


Related Trials